Introduction
The clinical use of thiazides in nephrogenic diabetes insipidus
One of the great advances in the therapy of renal disease occurred in the 1930s and was the synthesis of Drugs are the most important causes of NDI [3] . This orally administered diuretic compounds. In 1937 condition is characterized by unresponsiveness of the suphanilamides had been introduced as antimicrobio-kidney to the action of vasopressin. Thus, the adminislogical agents. In patients treated with suphanilamides, tration of desmopressin (dDAVP, a vasopressin anametabolic acidosis with alkaline urine was observed. logue acting on the V 2 type vasopressin receptor only) Pursuance of this phenomenon led to the accidental or of other drugs that potentiate arginine-vasopressin, discovery of the diuretic effect of suphanilamides. In such as carbamazepine, are not effective in NDI. In 1940 it was found that some suphanilamides inhibited drug-induced NDI, the treatment of choice is obviously carboanhydrase. An intensive search for suphanilam-elimination of the responsible drug [3] . Nevertheless, ides without carboanhydrase inhibition led to the syn-in many cases, such as lithium therapy for affective thesis of benzothiazide by Novello and Sprague [1] . disorders, discontinuance of the drug is often not Subsequently, numerous congeners were synthesized feasible because alternative drugs with comparable which are widely used today.
therapeutic effect are not available. In this psychiatric illness, apart from the bothersome symptoms of diabetes insipidus, persistence of polyuria carries the risk of dehydration with decreased lithium clearance and
Action of thiazide diuretics
conversely increased serum lithium concentrations and the potential risk of lithium intoxication. The only The principal site of thiazide action is the distal con-therapeutic approach is sodium restriction or adminisvoluted tubule, where they inhibit the NaCl cotrans-tration of thiazide diuretics or both. In 1905, Meyer porter in the luminal membrane, thus decreasing the (in [4] ) was the first to observe that diuretics decrease Cl− and Na+ reabsorption. In 1990 Tran et al. [2] urinary volume in diabetes insipidus, but it was only studied metolazone, a thiazide type diuretic and sug-in 1959 that Crawford and Kennedy [5] used thiazides gested that thiazides occupy the Cl− binding site of to treat this form of diabetes insipidus in rats. In 1961 the Na+Cl− cotransporter. In this position, metolazone the same authors administered thiazides to patients impedes the chloride entrance into the transporter with NDI [6 ] . Since that time, thiazides have been an molecule, thus blocking the reabsorption of the ion. important element in the treatment of NDI [7] . The principal adverse effect produced by thiazides is Although it seems paradoxical to treat polyuria with potassium loss with consecutive hypokalaemia. Such a diuretic, a net decrease of urine flow occurs with potassium loss is basically due to (i) enhanced delivery lowering of urine volumes to normal or only slightly of sodium to late nephron segments, (ii) inhibition of elevated values (e.g. typically from 8-10 litres to 4 carbonic anhydrase with a consecutive decrease of the litres or less per day). distal delivery of chloride, and (iii) stimulation of the apical K-Cl symporter in principal cells of the distal tubule.
The principal indications for the use of thiazides are
Proposed mechanisms of action (i) oedematous states and (ii) hypertension of patients with preserved renal function. Ancillary indications are
The following mechanism has been proposed to hypercalciuria, nephrolithiasis, and nephrogenic account for the effect of thiazides in this condition diabetes insipidus (NDI ).
[6,8]. An initial reduction of sodium reabsorption in the distal tubule increases sodium excretion and causes extracellular fluid volume contraction. As a result, the
Correspondence and offprint requests to: Antonio J. Magaldi MD, glomerular filtration rate decreases and the proximal Lab. Pesquisa Básica-LIM 12 Nephrology, Hospital das Clínicas da tubular sodium and water reabsorption increases. Consequently, less water and sodium are delivered to the collecting tubules and, as a result, less water is luminal side whilst the vasopressin receptor is located in the basolateral side. Thiazide obviously must enter excreted. This is schematically shown in Figure 1 .
Takemura [9] recently performed a long-term study the cell through the luminal membrane in order to gain access to the cytosol. in dogs with congenital NDI on a low-sodium diet, treated with a low dose of hydrochlorothiazide It had been noted that in patients with congenital NDI, urinary prostaglandin E 2 excretion was increased (2 mg/kg twice daily). The authors observed a significant decrease of urinary volume. Nevertheless, matters [12] . This led to attempts to use indomethacin, a prostaglandin E 2 synthesis blocker, together with are more complex. Shirley et al. [10] and others [8] noted that the decrease of solute reabsorption in the thiazides [13] . It is well known that prostaglandin E 2 decreases water absorption by decreasing the vasopresdistal nephron segments alone merely enhances urinary osmolality without changing urinary volume. To sin-induced water permeability in the IMCD [14, 15] .
Conversely, a prostaglandin inhibitor increases water explain the final effect of the drug, a direct or indirect action of thiazides on water flux in distal segments has absorption and decreases urinary volume. Instead of using indomethacin, we used prostaglandin E 2 itself in been proposed. our experiments; this was added to the bath of the perfusion system. Addition of prostaglandin decreased
Microperfusion studies on the inner medullary the thiazide effect. This observation explains why indomethacin potentiates the thiazide effect. Prostaglandin collecting duct (IMCD) E 2 inhibits the adenylate cyclase that is stimulated by vasopressin. Such inhibition of the adenylate cyclase Cesar and Magaldi [11] performed a study on normal constitutes a 'negative feedback loop' in the vasopressin rat inner medullary collecting duct. It was the principal cascade, since vasopressin stimulates the synthesis of aim to search for the above postulated effect of thiazprostaglandin E 2 in IMCD. ides in the distal nephron in addition to the ones To exclude the possibility that the above results are already known. A further aim was to elucidate why explained as an artefact resulting from inhibition of co-administration of indomethacin is effective in the the Na+Cl− cotransporter, we adopted the followtreatment of NDI.
ing strategy. We added ouabain, an inhibitor of The IMCD was chosen because of the consideration NaK-ATPase to our system. This did not abrogate the that water reabsorption mainly takes place in this effect of thiazides on water transport, leading us to segment. The technique used was 'in vitro' microperfuconclude that thiazide-stimulated water transport is sion, which permits the examination of this segment not linked to inhibition of the NaCl cotransporter. in isolation. The results showed that in the absence of
The results show that thiazides act only when they vasopressin, hydrochlorothiazide, when added to the are applied to the luminal side. This finding led us to luminal (but not the basolateral ) side, increased conclude that thiazides do not directly interact with osmotic and diffusional water permeabilities. Increased the vasopressin receptor, which is located at the basopermeability facilitates water reabsorption in the lateral side. The data on the effect of prostaglandin terminal nephron segment, thus decreasing urinary E 2 , and the results from our laboratory that an inhibvolume. This effect was also shown in rats with congenitor of protein kinase A blocks the effect of thiazide ital central diabetes insipidus (Brattleboro rats). These (unpublished data) led us to the hypothesis that the data confirm the hypothesis proposed [8,10] that thiazaction of thiazides takes place at some point in the ides act in segments beyond the distal tubule. The vasopressin cascade inside the cell. The exact mechaneffect is seen only when a diuretic is applied to the ism of this thiazide-mediated effect obviously requires further investigation.
Some practical points
First, the clinician has to be aware that there is more than one reason to explain polyuria. When thiazides are used in primary NDI or patients on lithium treatment, potassium depletion may occur. Potassium depletion per se causes polydipsia and vasopressinresistant polyuria. To prevent hypokalaemia, addition of the potassium-sparing diuretic amiloride has been recommended [16 ] . This inhibits the apical Na+ channel in the cortical collecting duct, thus diminishing the activity of the NaK-ATPase in the basolateral membrane and also K+ entry into the cell. These effects provide a diminished driving force for K+ secretion. This explains the beneficial effect of amiloride in 
